Stay updated on Nivolumab+Vorolanib Safety/Activity in Thoracic Tumors Clinical Trial
Sign up to get notified when there's something new on the Nivolumab+Vorolanib Safety/Activity in Thoracic Tumors Clinical Trial page.

Latest updates to the Nivolumab+Vorolanib Safety/Activity in Thoracic Tumors Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, indicating a minor editorial/documentation update. This change does not modify the core study details and appears to be a routine version bump.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedThe page’s footer has been updated from “Revision: v3.5.2” to “Revision: v3.5.3,” indicating a website release/version change rather than a change to the clinical trial study details.SummaryDifference0.0%

- Check36 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check50 days agoChange DetectedAdded Small cell lung carcinoma to the conditions list and included a Genetic and Rare Diseases Information Center resource entry.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision: v3.5.0 has been added and the previous revision v3.4.3 has been removed.SummaryDifference0.0%

- Check72 days agoChange DetectedRevision notes updated: added Revision: v3.4.3 and removed Revision: v3.4.2. These are backend/versioning updates and do not change the study details or user-facing content on the page.SummaryDifference0.0%

Stay in the know with updates to Nivolumab+Vorolanib Safety/Activity in Thoracic Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab+Vorolanib Safety/Activity in Thoracic Tumors Clinical Trial page.